3 edition of Biologic and synthetic vascular prostheses found in the catalog.
|Statement||editor, James C. Stanley.|
|Contributions||Stanley, James C., University of Michigan. Dept. of Surgery., University of Michigan. Dept. of Postgraduate Medicine and Health Professions Education.|
|LC Classifications||RD598.5 .B56 1982|
|The Physical Object|
|Pagination||xxi, 681 p. :|
|Number of Pages||681|
|LC Control Number||82003103|
Cardiac Valves: Biologic and Synthetic. were fabricated and seeded with vascular cells from an ovine carotid artery. world are actively investigating cardiovascular prostheses of. Although bioengineering of vascular prosthetic grafts is one of the many multi-disciplinary areas of research, the book concentrates on the biological aspects of the field. For example, the book includes a fine review of the recent advances made in the areas of tissue by: 1.
ProCol is a bovine mesenteric vein vascular bioprosthesis with numerous clinical publications and presentations showing good outcomes in hemodialysis access since (2,4,9,10,12,13) ProCol shows 57% and 54% secondary patency at 2 and 3 years, compared to 18% and 10% with ePTFE, in patients with a previously failed synthetic graft.(2) Indications for Use The ProCol Vascular Bioprosthesis is. book, is any synthetic material that is used to biological degradation in polymers) polymers are the material of choice for vascular prostheses (see Chapter 7, “Polymeric Materi-als,” in this handbook for further details). Ophthalmics. The tissues of the eye can.
Appropriate mechanical properties and fast endothelialization of synthetic grafts are key to ensure long-term functionality of implants. We used a newly developed biostable polyurethane elastomer (TPCU) to engineer electrospun vascular scaffolds with promising mechanical properties (E-modulus: ± MPa, burst pressure: ± 78 mmHg), which were biofunctionalized with fibronectin (FN. Synthetic small diameter vascular grafts have a high failure rate, and endothelialization is critical for preventing thrombosis and graft occlusion. A promising approach is in situ tissue engineering, whereby an acellular scaffold is implanted and provides stimulatory cues to guide the in situ remodeling into a functional blood vessel. An ideal Cited by:
crisis of the early Italian Renaissance
Salary of judge in Second Judicial Circuit. Letter from the Secretary of the Treasury, submitting an urgent deficiency estimate of appropriation for salary of additional judge in the Second Judicial Circuit.
Irish crafts for children
Assessment of childhood disorders
The adventures of an economic migrant
Make-overs From Mens Suits
Analysis of borehole-radar reflection logs from selected HC boreholes at the Project Shoal Area, Churchill County, Nevada
The Non-conformists plea for uniformity
The counterair companion
The nigger of the Narcissus
Medicare, millions can be saved by screening claims for overused services
Proposals for the prevention of future wars
The second chapter succinctly discusses the biologic interactions of currently available vascular prostheses with regard to modes of failure, thrombogenicity, anastomotic pseudointimal hyperplasia, and by: 1.
Biologic and synthetic vascular prostheses. New York: Grune & Stratton, © (OCoLC) Material Type: Conference publication: Document Type: Book: All Authors / Contributors: James C Stanley; University of Michigan. Department of Surgery.; University of Michigan.
Department of Postgraduate Medicine and Health Professions Education. New Biologic and Synthetic Vascular Prostheses by Howard P. Greisler,available at Book Depository with free delivery worldwide.
Additional Physical Format: Online version: Greisler, Howard P. New biologic and synthetic vascular prostheses. Austin: R.G. Landes Co., (OCoLC) Abstract.
The progression of atherosclerosis is often relentless and, despite the numerous treatment options, recurrent disease is common. Vascular prosthetic implants are prone to failure, resulting in significant morbidity, cost, discomfort, and inconvenience for the patient. Surveillance protocols of vascular prostheses (grafts, stents.
This practical and comprehensive book provides "how-to" information on all aspects of access to the vascular system for hemodialysis, parenteral nutrition, chemotherapy, and resuscitation.
Preoperative evaluation, operations, noninvasive procedures, complications, and other aspects are detailed. This edition provides increased coverage of non-interventional techniques and includes new chapters 5/5(1). Synthetic prostheses are usually made from PTFE or polyester.
Biologic and synthetic vascular prostheses book prostheses may be either allografts or xenografts. Allografts are blood vessels from humans e.g. cadaveric blood vessel grafts, removed varicose veins are human umbilical vein grafts (HUVG). Abstract.
The function of vascular grafts is to transport blood and the dominant concern in their design is preventing thrombosis. A graft must conserve propulsive energy as much as possible and must activate clotting mechanisms as little as by: Knitted and Woven Collagen Impregnated Vascular Prostheses.
XenoSure ® Biologic Pledgets. The Biologic Alternative to Synthetic Pledgets. AnastoClip GC ® Closure System. 50% Higher Retention Force (1) For a More Secure Anastomosis. AnastoClip ® AC Closure System.
Now Available in 8 cm & 15 cm Lengths. ProCol ® Vascular Bioprosthesis. Request PDF | Novel Synthetic Selectively Degradable Vascular Prostheses: A Preliminary Implantation Study | Vascular grafts perform less well than. Full text Full text is available as a scanned copy of the original print version.
Get a printable copy (PDF file) of the complete article (K), or click on a page image below to browse page by : R C Kester. Vascular grafts perform less well than autologous arterial or vein grafts.
The purpose of this study was to evaluate the short-term performance of selectively biodegradable filament-wound vascular prostheses, comprising elastomeric poly (ether urethane) (Lycra) scaffolds and flexible, hydrophilic biodegradable by: biologic and synthetic vascular prostheses and uses careflflly selected references in a clear and precise manner to present a balanced view of current knowledge.
This book is for the serious student of the biology of arterial prosthesis healing in the s. The point is well made in the first chapter on the. Download PDF: Sorry, we are unable to provide the full text but you may find it at the following location(s): g (external link)Author: R C Kester.
Download PDF: Sorry, we are unable to provide the full text but you may find it at the following location(s): g (external link)Author: John M. Porter. Supported in part by Grants HE and HE from the United States Public Health Service.
Moursund Avenue Houston, Texas Basic Biologic Reactions to Vascular Grafts and Prostheses Michael E. De Bakey, M.D., F.A.C.S. George L. Jordan, by: He has authored more than scientific articles and textbook chapters.
He served as editor of the Journal of Vascular Surgery from Stanley has edited 10 books, including two on renovascular hypertension, one on biologic and synthetic vascular prostheses, and four editions of Current Therapy in Vascular Surgery. Co-directors. Biologic and Synthetic Vascular Prostheses.
(PMCID:PMC) Full Text Citations ; BioEntities ; Related Articles ; External Links ; J R Soc Med. May; 76(5): – PMCID: PMC Biologic and Synthetic Vascular Prostheses.
Reviewed by R C Kester. terminology for sterile tubular vascular prostheses intended to replace, bypass or to form shunts between segments of the vascular system in International Standard addresses vascular prostheses that are made wholly or partly of: materials of biological origin; synthetic textile materials; and synthetic nontextile materials.
This International Standard specifies requirements relating to testing, packaging, labelling and terminology for sterile tubular vascular prostheses intended to replace, bypass or to form shunts between segments of the vascular system in International Standard addresses vascular prostheses that are made wholly or partly of: materials of biological origin; synthetic textile materials; and synthetic Manufacturer: Multiple.
Distributed through American National Standards Institute. Vascular prostheses that are made of synthetic textile materials and synthetic non-textile materials are within the scope of ISO While vascular prostheses that are made wholly or partly of materials of non-viable biological origin, including tissue engineered vascular prostheses are within the scope, ISO does not address Category: p.Cardiovascular biomaterials (CB) dominate the category of biomaterials based on the demand and investments in this field.
This review article classifies the CB into three major classes, namely, metals, polymers, and biological materials and collates the information about the CB. Blood compatibility is one of the major criteria which limit the use of biomaterials for cardiovascular by: Establishes requirements for testing synthetic textile, synthetic non-textile, biologic, composite, and compound vascular prostheses.
It includes requirements for labeling, testing the physical and mechanical properties of the device, and for in vivo testing and clinical assessment.